Get Policy Expertise

If the recent CMS rescinding of the MCIT rule has reminded us of anything, it’s that the medtech landscape is constantly shifting and building a strategy on an ever-changing policy landscape is not for the faint of heart. When our CEO was a recent guest on Life Science Success podcast and was asked what her biggest concern was, her answer was policy.

As we’ve heard our CEO, Dr. April Zambelli-Weiner, talk about before, a market access plan should be 3 things:

  1. Holistic
  2. Realistic
  3. Flexible

Flexible includes having experts who regularly monitor and revisit the policy landscape to incorporate new information and changing market dynamics into your plan.

Not having a handle on the shifting policy landscape could mean you waste precious time and resources going down the wrong path (at best). At worst, a misstep could not just mean the end of your company, you could be facing civil and criminal charges. Products with laboratory testing components are at particular risk.

Schedule Time with Our Very Own Med Tech Gurus